Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 22, 2026 | Independence Blue Cross | Pegloticase (Krystexxa) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | patisiran (Onpattro) and vutrisiran (Amvuttra) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Omalizumab (Xolair) and related biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | olipudase alfa-rpcp (Xenpozyme) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Octreotide Acetate (Sandostatin LAR Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nogapendekin alfa inbakicept-pmln (Anktiva) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nivolumab and relatlimab-rmbw (Opdualag) for intravenous use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nipocalimab-aahu (Imaavy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Natalizumab (Tysabri) and Related Biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mosunetuzumab-axgb (Lunsumio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mogamulizumab-kpkc (Poteligeo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mirvetuximab soravtansine-gynx (Elahere) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Margetuximab-cmkb (Margenza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Luspatercept–aamt (Reblozyl) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lurbinectedin (Zepzelca) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lumasiran (Oxlumo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Loncastuximab tesirine-lpyl (Zynlonta) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Linvoseltamab-gcpt (Lynozyfic) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lanreotide (Somatuline Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Isatuximab-irfc (Sarclisa) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ipilimumab (Yervoy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Intravenous Infliximab and Related Biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Interleukin-5 (IL-5) Antagonist (e.g., Cinqair, Exdensur, Nucala) and IL-5 Receptor Antagonist (e.g., Fasenra) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Inebilizumab-cdon (Uplizna) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Inclisiran (Leqvio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Imetelstat (Rytelo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Guselkumab (Tremfya) Injection for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Golimumab (Simponi Aria) Intravenous (IV) Injection | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Glofitamab-gxbm (Columvi) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Givosiran (Givlaari) and Panhematin (Hemin) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Filgrastim (Neupogen) and Related Biosimilars, and Tbo-filgrastim (Granix) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Fam-trastuzumab deruxtecan-nxki (Enhertu) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Evinacumab-dgnb (Evkeeza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Eptinezumab-jjmr (VYEPTI) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Epcoritamab-bysp (EPKINLY) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme, Elaprase, Vimizim, Naglazyme, Mepsevii, etc.) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Enfortumab vedotin-ejfv (Padcev) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Emapalumab-lzsg (Gamifant) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Elranatamab-bcmm (Elrexfio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Efgartigimod alfa-fcab (Vyvgart) and efgartigimod-alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Efbemalenograstim alfa-vuxw (Ryzneuta), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim (Neulasta) and Related Biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Eculizumab (Soliris) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris) for intravenous administration | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Dostarlimab-gxly (Jemperli) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Denosumab (Prolia, Xgeva) and related biosimilars, and Romosozumab-aqqg (Evenity) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Datopotamab deruxtecan (Datroway) | Codes changed |